Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-30 @ 11:52 PM
Study NCT ID:
NCT06789757
Status:
RECRUITING
Last Update Posted:
2025-10-07
First Post:
2024-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
Sponsor:
Inova Health Care Services
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
INOVA-2023-74
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None